The investment seeks high current income consistent with what Franklin Advisers, Inc... Show more
Category IntermediateTermBond
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JABRX | 47.46 | 0.04 | +0.08% |
| Janus Henderson Balanced S | |||
| GEMCX | 20.99 | N/A | N/A |
| Goldman Sachs Emerging Markets Eq C | |||
| NBHCX | 14.40 | N/A | N/A |
| Neuberger Berman Equity Income C | |||
| TIAGX | 12.52 | N/A | N/A |
| Timothy Plan Small/Mid Cap Growth Cl I | |||
| AWGIX | 39.86 | N/A | N/A |
| CIBC Atlas All Cap Growth Institutional | |||
A.I.dvisor tells us that PCRB and SPAB have been poorly correlated (+-0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRB and SPAB's prices will move in lockstep.
| Ticker / NAME | Correlation To PCRB | 1D Price Change % | ||
|---|---|---|---|---|
| PCRB | 100% | +0.35% | ||
| SPAB - PCRB | -0% Poorly correlated | +0.32% | ||
| BIV - PCRB | -1% Poorly correlated | +0.38% | ||
| BND - PCRB | -2% Poorly correlated | +0.32% | ||
| AGG - PCRB | -2% Poorly correlated | +0.34% | ||
| SCHZ - PCRB | -2% Poorly correlated | +0.44% |